Aβ42, Aβ40 and P-Tau proteins in CSF have been included in the scientific research criteria for the diagnosis of AD (Charidimou et al., 2018; Mila-Aloma et al., 2020). The gene discussed is MAPT; the disease is Alzheimer disease.